---
title: "Home"
description: "Need genetically engineered mice? VeloGene provides rapid mouse model generation in 45 days. Get F0 homozygous models via our proprietary TurboMice™ technology."
featured_image: "https://velogene.com/wp-content/uploads/2026/11/feature-image.webp"
url: "https://velogene.com/"
date_modified: "2026-11-13T13:35:24+08:00"
---

# VeloGene Biotechnology

## F0 Homozygous Mouse Models

##### 2× Faster Than Traditional Approches

[KO](https://velogene.com/products-services/services/mouse-model-customize/knockout/) · [cKO](https://velogene.com/products-services/services/mouse-model-customize/cko/) · [KI](https://velogene.com/products-services/services/mouse-model-customize/knockin/) · [Humanized](https://velogene.com/products-services/services/mouse-model-customize/humanize/) · [Point Mutation](https://velogene.com/products-services/services/mouse-model-customize/point-mutation/) · [Transgenic](https://velogene.com/products-services/services/mouse-model-customize/transgenic/)

![](https://velogene.com/wp-content/uploads/2026/06/certi-web.png)

## Media Carousel

![DMD-homeback](https://velogene.com/wp-content/uploads/2026/07/DMD-homeback-e1787652015491.jpg?ver=1785288242)

[Link](https://velogene.com/vison-partnership/dmd-genassist/)

![cover-whitemouse](https://velogene.com/wp-content/uploads/2026/09/cover-whitemouse.png)

---

#### Custom Models

#### Strains in Stock

#### Research Service

---

Humanize

- Multi-Site Customization on Same Chromosome
- Minimum Genetic Drift

[](https://velogene.com/products-services/services/mouse-model-customize/humanize/)

KO

- KO homozygous with identical alleles
- Homozygous mice: as little as 3 months

[](https://velogene.com/products-services/services/mouse-model-customize/knockout/)

KI

- Rosa 26/H11 KI
- High-efficiency long-range knock-in （~100kb）
- Homozygous mice: as little as 3 months

[](https://velogene.com/products-services/services/mouse-model-customize/knockin/)

cKO

- F0 100% targeted Geneflox/flox ; Cre+
- F0 models in 4–6 months via tetraploid ESC engineering.

[](https://velogene.com/products-services/services/mouse-model-customize/cko/)

Point Mutation

- Single-Chromosome Multiplex Editing
- ESC homologous recombination, precise introduction of target mutations

[](https://velogene.com/products-services/services/mouse-model-customize/point-mutation/)

---

## What is TurboMice™？

**TurboMice™** by Dr. Wu Guangming redefines animal model generation through **Tetraploid Complementation Technology (TCT)** and precision stem cell engineering. Bypassing traditional multi-generational breeding and chimeric phases, the platform drives edited Embryonic Stem Cells (ESCs) directly into fully homozygous cohorts.

- **Accelerated Timelines:** 45-day turnaround from cell line validation to functional models; full in vivo readiness in 3 to 5 months.
- **Uncompromising Precision:** Direct homozygous development ensures exceptional genetic consistency and eliminates off-target risks common in standard CRISPR workflows.
- **Global Enterprise Grade:** SPF-grade genetically engineered mouse models and end-to-end technical support for elite research centers and biopharmaceutical enterprises worldwide.

[Learn More](https://velogene.com/en/why-velogene/turbomice/)

---

## About VeloGene Biotechnology

As a fully-owned subsidiary of MingCeler Biotech, **VeloGene Biotechnology** delivers custom, SPF-grade genetically engineered mouse models to multinational pharmaceutical firms and global research labs. Powered by MingCeler's game-changing **TurboMice™** tetraploid complementation technology, we eliminate slow chimera breeding cycles to deliver fully homozygous mouse strains in just 2 to 5 months, dramatically accelerating preclinical research in rare diseases, oncology, and gene therapy.

---

![](https://velogene.com/wp-content/uploads/2026/09/image-5.png)

02 September 2026

Client Case: Super SOX factors enable cross-species cell diversity

Induced pluripotent stem cells (iPSCs) are generated by reprogramming differentiated somatic cells back...

[Read More](https://velogene.com/client-case/supersox/)

## VeloGene

## Client Case

---

## VeloGene News

[](https://velogene.com/article/preclinical/turbomice-breaks-through-gjb2-deafness-mice/)

03 November 2026

[Why Are GJB2 Deafness Mice So Hard to Build? How TurboMice™ Breaks Through](https://velogene.com/article/preclinical/turbomice-breaks-through-gjb2-deafness-mice/)

[Read More](https://velogene.com/article/preclinical/turbomice-breaks-through-gjb2-deafness-mice/)

[](https://velogene.com/article/preclinical/turbomice-breaks-through-gjb2-deafness-mice/)

[](https://velogene.com/marketingactivities/news/velogene-biotechnology-congratulates-partner-accuredit-therapeutics-on-receiving-us-fda-ind-clearance-for-in-vivo-gene-editing-therapy-art001/)

05 August 2026

[VeloGene Biotechnology Congratulates Partner AccurEdit Therapeutics on Receiving US FDA IND Clearance for In Vivo Gene Editing Therapy ART001](https://velogene.com/marketingactivities/news/velogene-biotechnology-congratulates-partner-accuredit-therapeutics-on-receiving-us-fda-ind-clearance-for-in-vivo-gene-editing-therapy-art001/)

[Read More](https://velogene.com/marketingactivities/news/velogene-biotechnology-congratulates-partner-accuredit-therapeutics-on-receiving-us-fda-ind-clearance-for-in-vivo-gene-editing-therapy-art001/)

[](https://velogene.com/marketingactivities/news/velogene-biotechnology-congratulates-partner-accuredit-therapeutics-on-receiving-us-fda-ind-clearance-for-in-vivo-gene-editing-therapy-art001/)

[](https://velogene.com/marketingactivities/news/genassist-ltd-and-velogene-announce-global-access-to-validated-humanized-dmd-mouse-models-to-accelerate-global-dmd-drug-development/)

17 July 2026

[GenAssist Ltd and VeloGene Biotechnology Announce Global Access to Validated Humanized DMD Mouse Models to Accelerate Global DMD Drug Development](https://velogene.com/marketingactivities/news/genassist-ltd-and-velogene-announce-global-access-to-validated-humanized-dmd-mouse-models-to-accelerate-global-dmd-drug-development/)

[Read More](https://velogene.com/marketingactivities/news/genassist-ltd-and-velogene-announce-global-access-to-validated-humanized-dmd-mouse-models-to-accelerate-global-dmd-drug-development/)

[](https://velogene.com/marketingactivities/news/genassist-ltd-and-velogene-announce-global-access-to-validated-humanized-dmd-mouse-models-to-accelerate-global-dmd-drug-development/)

[](https://velogene.com/marketingactivities/news/guangzhou-mingceler-biotech-signs-strategic-mou-with-hankook-kinetico-engineering/)

22 June 2026

[Guangzhou MingCeler Biotech Signs Strategic MOU with Hankook Kinetico Engineering in South Korea to Roll Out Custom Gene-Edited Mouse Models](https://velogene.com/marketingactivities/news/guangzhou-mingceler-biotech-signs-strategic-mou-with-hankook-kinetico-engineering/)

[Read More](https://velogene.com/marketingactivities/news/guangzhou-mingceler-biotech-signs-strategic-mou-with-hankook-kinetico-engineering/)

[](https://velogene.com/marketingactivities/news/guangzhou-mingceler-biotech-signs-strategic-mou-with-hankook-kinetico-engineering/)

[](https://velogene.com/marketingactivities/asgct-2026-concludes-successfully-turbomice-technology-links-global-cgt-innovation/)

19 May 2026

[ASGCT 2026 Concludes Successfully | TurboMice™ Technology Links Global CGT Innovation](https://velogene.com/marketingactivities/asgct-2026-concludes-successfully-turbomice-technology-links-global-cgt-innovation/)

[Read More](https://velogene.com/marketingactivities/asgct-2026-concludes-successfully-turbomice-technology-links-global-cgt-innovation/)

[](https://velogene.com/marketingactivities/asgct-2026-concludes-successfully-turbomice-technology-links-global-cgt-innovation/)

[](https://velogene.com/marketingactivities/conference-spotlight-turbomice-tetraploid-complementation-technology-accelerates-new-drug-rd/)

13 May 2026

[Conference Spotlight: TurboMice™ Tetraploid Complementation Technology Accelerates New Drug R&D](https://velogene.com/marketingactivities/conference-spotlight-turbomice-tetraploid-complementation-technology-accelerates-new-drug-rd/)

[Read More](https://velogene.com/marketingactivities/conference-spotlight-turbomice-tetraploid-complementation-technology-accelerates-new-drug-rd/)

[](https://velogene.com/marketingactivities/conference-spotlight-turbomice-tetraploid-complementation-technology-accelerates-new-drug-rd/)

[](https://velogene.com/marketingactivities/invitation-mingceler-at-asgct-2026-annual-meeting-in-boston-online/)

08 May 2026

[Invitation | MingCeler at ASGCT 2026 Annual Meeting in Boston & Online](https://velogene.com/marketingactivities/invitation-mingceler-at-asgct-2026-annual-meeting-in-boston-online/)

[Read More](https://velogene.com/marketingactivities/invitation-mingceler-at-asgct-2026-annual-meeting-in-boston-online/)

[](https://velogene.com/marketingactivities/invitation-mingceler-at-asgct-2026-annual-meeting-in-boston-online/)

---

## VeloGene Certification

![AAALAC-VeloGene](https://velogene.com/wp-content/uploads/2026/06/AAALAC证书扫描件_01-updraft-pre-smush-original-e1782095948262.png)

![ISO VeloGene](https://velogene.com/wp-content/uploads/2026/06/ISO-sets-e1781157755828.png)

![China Lab Animal Production Certificate](https://velogene.com/wp-content/uploads/2026/06/试验动物生产许可证.png)